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Effect of glycation of albumin on its renal clearance in normal
and diabetic rats
GARY J. LAYTON and GEORGE JERUMS
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Effect of glycation of albumin on its renal clearance in normal and
diabetic rats. Two independent techniques have been used to study the
renal clearances of nonenzymatically glycated albumin and nonglycated
albumin in normal and streptozotocin-induced diabetic rats, 16 to 24
weeks after the onset of diabetes. In the first technique, serum and
urinary endogenous glycated and nonglycated albumin were separated
using m-aminophenylboronate affinity chromatography and subsequently
quantified by radioimmunoassav. Endogenous glycated albumin was
cleared approximately twofold faster than nonglycated albumin in
normal and diabetic rats. However, no difference was observed in the
glycated albumin/nonglycated albumin clearance ratios (Cga/Calb) in
normal and diabetic rats, respectively (2.18 0.39 vs 1.83 0.22, P >
0.05). The second technique measured the renal clearance of injected
'251-Iabelled glycated albumin and '25l-labelled albumin. The endoge-
nous results were supported by the finding that '251-labelled glycated
albumin was cleared more rapidly than '251-labelled albumin in normal
(P < 0.01) and diabetic (P < 0.05) rats. The Cga/Calb ratio calculated
for the radiolabelled albumins was 1.4 and 2.0 in normal and diabetic
rats, respectively. This evidence suggests that nonenzymatic glycation
of albumin increases its renal clearance to a similar degree in normal
and diabetic rats.
Nonenzymatic glycation of plasma and tissue proteins is
enhanced during hyperglycemia, and there has been speculation
that it may contribute to the pathogenesis of diabetic compli-
cations in man [1]. Studies carried out in humans have sug-
gested that glycation of albumin alters its renal handling.
However, there is no agreement as to whether glycated albumin
is cleared faster [2—51, at the same rate 161, or slower than
nonglycated albumin [71 in normal subjects.
These conflicting results in man may reflect methodological
problems as well as biological differences in the subjects
studied. The present study is the first to examine the renal
handling of glycated albumin in normal and streptozotocin
diabetic rats before the onset of albustix positive proteinuria.
Two independent techniques have been used, enabling direct
measurement of the renal clearance of native and radiolabelled
albumin.
Methods
Protocol
Male Wistar Kyoto rats aged 24 to 32 weeks were used for
studies of endogenous and exogenous glycated albumin clear-
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ance. Additional studies were performed in age-matched dia-
betic rats 16 to 24 weeks after induction of diabetes by intrave-
nous injection of streptozotocin at eight weeks of age in a dose
of 60 mg/kg. Urine collections were carried out over a twenty-
four hour period using metabolic cages. Blood was sampled
from the tail vein, and serum was separated immediately. Urine
and serum samples were stored at —20°C until the day of assay.
Endogenous albumin clearance
Glycated albumin was first separated from nonglycated albu-
min in serum and urine samples by m-aminophenylboronate
affinity chromatography, using 1 ml columns (Glycoglobin kit,
Endocrine Sciences). Serum samples (10 l) were applied
directly to the columns. Aliquots of urine were concentrated
40-fold to a volume of 50 d prior to chromatography using
Minicon concentrators (Amicon, Lexington, Massachusetts,
USA). Recovery from the concentration step was 66 3% for
glycated albumin and 61 10% for albumin. Nonglycated
albumin was removed during chromatography with 10 ml of
buffer containing 0.05 M MgCI2 and 0.25 M CH3COONH4, pH
8.5. Glycated albumin was then eluted in 5 ml of buffer
containing 0.2 M sorbitol, 50 mrvi EDTA and 0.1 M Tris, pH 8.5.
The concentration of albumin in each fraction of the column
eluate was determined by radioimmunoassay and the ratio of
glycated to nonglycated albumin was calculated. The recovery
of glycated albumin and nonglycated albumin from the affinity
columns was 34 3% and 40 5%, respectively. The perform-
ance characteristics of the m-aminophenylboronate columns
used in this study were determined by analysis of a single
diabetic serum sample using 10 different columns. The amount
of glycated albumin measured in this sample, as a percentage of
total albumin, was 9.8 0.5% (mean cv:15.l%. The
ratio of glycated albumin to nonglycated albumin (ga/alb) eluted
from the columns was independent of the amount of serum
loaded onto the columns. The columns were >94% efficient in
their ability to discriminate between glycated and nonglycated
albumin standards prepared in our laboratory.
The rat albumin radioimmunoassay was performed using a
coated tube technique adapted to microtiter plates [81. Rat
albumin (Calbiochem) was iodinated by the chioramine T
method [91. Rat albumin antibody was obtained from Cappel
Laboratories (Cochranville, Pennsylvania, USA). The detec-
tion limit of the rat albumin assay was 15.6 ng/ml and coeffi-
cients of intra-assay and interassay variation were 5.2% and
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Table 1. Renal clearance of endogenous glycated albumin (ga) and nonglycated albumin (alb) in normal and diabetic rats. (U: urine, S: serum,
%: ga/(alb+ga). 100 and C: clearance)
Normal
U aib
jsg/24hr
U ga
pg/24hr % U ga
S aib
mg/mi
S ga
mg/mi % S ga
C alb
ni/sec
C ga
ni/sec C ga/C aib
209.6
135.0
60.4
64.5
249.6
148.2
247.0
19.5
211.9
9.1
81.6
120.6
253.8
276.0
8.3
5.4
8.8
11.9
13.8
10.0
10.3
2.3
15.8
0.9
13.8
5.1
30.4
12.2
3.8
3.8
12.7
15.6
5.2
6.3
4.0
10.6
6.9
9.0
14.5
4.1
10.7
4.2
25.6
26.8
21.9
26.8
34.0
26.4
25.2
13.9
27.0
34.6
40.2
38.4
9.3
68.5
0.73
0.64
1.22
0.86
2.51
1.94
0.69
0.25
0.71
2.70
2.76
1.69
0.47
3.67
2.8
2.3
5.3
3.1
6.9
6.8
2.7
1.8
2.6
7.2
6.4
4.2
4.8
5.1
0.09
0.06
0.03
0.03
0.08
0.07
0.11
0.02
0.09
0.003
0.02
0.04
0.32
0.05
0.13
0.10
0.08
0.16
0.06
0.06
0.17
0.10
0.26
0.004
0.06
0.04
0.75
0.04
1.44
1.60
2.67
5.33
0.75
0.86
1.55
5.00
2.89
1.33
3.00
1.00
2.34
0.80
149 24.7 10.6 1.9 8.0 1.1 29.9 3.7 1.5 0.3 4.4 0.5 0.07 0.02 0.14 0.05 2.18 0.39
Diabetic
U alb
p.g/24hr
U ga
,ug/24hr % U ga
S alb
mg/mi
S ga
mg/mi % S ga
C alb
ni/sec
C ga
ni/sec C ga/C aib
666.0
804.6
362.3
267.0
63.6
79.8
312.4
935.0
1934.3
1167.3
275.0
42.3
42.0
331.5
16.8
36.9
32.6
31.5
10.2
13.1
37.4
195.8
230.0
44.9
23.1
7.2
9.0
26.0
2.5
4.4
8.2
10.6
13.8
17.1
10.7
17.3
10.6
3.7
7.7
14.5
17.6
7.2
19.5
22.7
23.7
11.8
20.6
23.0
12.1
8.5
8.3
18.7
24.6
13.1
18.9
21.2
0.62
0.73
0.9
0.49
1.41
1.8
1.19
1.52
1.05
0.83
1.4
1.3
1.02
1.46
3.1
3.1
3.7
4.0
6.4
7.3
9.0
15.2
11.2
4.2
5.4
9.0
5.1
6.4
0.40
0.41
0.18
0.26
0.04
0.04
0.30
1.27
2.70
0.72
0.06
0.03
0.03
0.18
0.31
0.59
0.42
0.74
0.08
0.08
0.36
1.49
2.54
0.82
0.19
0.06
0.10
0.21
0.78
1.44
2.33
2.85
2.00
2.00
1.20
1.17
0.94
1.14
3.17
2.00
3.33
1.17
520.2 144.1 51.0 18.7 10.4 1.4 17.6 1.5 1.1 0.1 6.7 0.9 0.47 0.19 0.57 0.18 1.82 0.22
10.6%, respectively. '251-albumin standard curves for glycated
and native albumin were identical.
Radio/abe/led albumin clearance
Rat albumin (20 mg) was nonenzymatically glycated by
incubation with 100 m glucose at 37°C for 21 days, in the
presence of streptomycin 100 ,ag/ml and penicillin 100 U/mI.
Subsequently, the glycated albumin was separated from resid-
ual nonglycated albumin by affinity chromatography using a 10
ml m-aminophenylboronate column. Glycated albumin, incu-
bated for five days at 37°C in the absence of glucose, was shown
to be stable when subjected to repeat affinity chromatography.
This technique produced a 0.2 mg yield of glycated albumin.
Glycated albumin was iodinated by the chloramine T method
[9], and then purified by Sephadex G-50 chromatography. The
radiolabelled protein was greater than 90% precipitable by
trichloroacetic acid prior to use. Glycated albumin retained its
affinity for m-aminophenylboronate following iodination. Spe-
cific activities ranged from 40 to 50 Ci/g and were similar for
'251-glycated albumin and '251-albumin. Each iodinated protein
(1.5 Ci) was then injected intravenously into two separate
groups of normal rats ('251-albumin, N 10; '251-glycated
albumin, N = 12). The experiment was repeated in two groups
of age-matched diabetic rats, 16 to 24 weeks after injection of
streptozotocin ('251-albumin, N = 7; '251-glycated albumin, N =
6). Following injection of the radiolabelled albumins, trichloro-
acetic acid-precipitable '251-proteiñ was measured in serial
plasma and urine samples. The determination of trichioroacetic
acid precipitability was performed by adding an equal volume of
20% trichloroacetic acid to the sample, followed by three steps
of centrifugation and washing in 10% trichloroacetic acid, until
the level of radioactivity in the precipitate was constant.
'251-protein concentration was shown to reach a steady state in
serum after 24 hours, The renal clearance of 1251-protein was
calculated using urine collected during the second 24 hours and
the mean of two serum samples taken at 24 and 48 hours.
Statistics
Paired Student's t-tests were used for analysis of endogenous
protein clearance and Wilcoxon signed-rank tests were used for
analysis of exogenous protein clearance. Results are expressed
as mean unless specified otherwise.
Results
Glycated albumin represented 4.4 0.5% and 6.7 0.9% of
total serum albumin in normal and diabetic rats, respectively (P
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Table 2. Renal clearance of iodinated albumins in normal and
diabetic rats, showing median and range of results
Glycated
Nonglycated albumin
nI/sec
albumin
ni/sec
Normal 0.59 (0.30—0.84)
N=lO
0.81 (o.53—l.63YN=l2
Diabetic 0.95 (0.63—2.27)N=7 1.91 (0.93_4.66)aN=6
P < 0.05 when compared with nonglycated albumin
<0.05). In urine, glycated albumin represented 8,0 1.1% and
10.4 1.4% of total albumin in normal and in diabetic rats,
respectively (P > 0.05). Endogenous glycated albumin clear-
ance was significantly greater than the clearance of nonglycated
albumin in normal (P < 0.05) and in diabetic (P < 0.05) rats.
However, no significant difference was observed in the glycated
albumin/nonglycated albumin clearance ratios (Cga/CaIb) be-
tween normal and diabetic rats (Table 1, P > 0.05).
'251-labelled glycated albumin was cleared significantly faster
than exogenous '251-labelled albumin in normal rats (P < 0.05)
and in diabetic rats (Table 2, P < 0.05). The glycated albumin!
nonglycated albumin clearance ratio was 1.4 in normal rats and
2.0 in diabetic rats, using median results for each group (Table
2).
A comparison between results of endogenous and radiola-
beled protein clearances showed that uncorrected endogenous
albumin and glycated albumin clearances were two- to ninefold
lower than the corresponding clearances of exogenous 1251
proteins. When endogenous albumin clearance results were
corrected for recovery from the concentration procedure, 125I
albumin clearance remained one- to fivefold higher than non-
isotopic albumin clearance and '251-glycated albumin remained
two- to fourfold higher than non-isotopic glycated albumin
clearance.
Total albumin clearance (glycated albumin plus nonglycated
albumin) was markedly greater in diabetic than in normal rats
when assessed by either the endogenous (P < 0.05) or the
radiolabelled (P < 0.01) techniques.
Isoelectric points of glycated and nonglycated rat albumin
were determined by isoelectric focusing using a polyacrylamide
slab gel on a LKB 2117 multiphor, fiat bed apparatus. Nongly-
cated albumin was characterized as a wide band ranging in
isoelectric point from 4.7 to 5.0. In comparison, glycated rat
albumin was more anionic than nonglycated rat albumin, with
an isoelectric point ranging from 4.4 to 4.7.
Discussion
This study has shown that glycated albumin is cleared by the
kidney more rapidly than nonglycated albumin in normal and
diabetic Wistar Kyoto rats. The same conclusion was reached
by two independent techniques, but differences were noted in
absolute protein clearance results as estimated by the endoge-
nous and exogenous techniques. The observed difference in
absolute estimates of exogenous and endogenous albumin clear-
ances are partly attributable to the loss of approximately 40% of
protein during the urinary concentration procedure. However,
the radiolabelling procedure itself may also account for an
increase in protein clearance as a result of a change in the
charge of the iodinated proteins. For example, incorporation of
iodine into the insulin molecule has been shown to affect its
metabolism [10]. There were no systematic differences in the
glycated albumin/nonglycated albumin clearance ratio observed
between diabetic and normal rats. This suggests that hypergly-
cemia of early diabetes in the rat does not affect the renal
clearance of glycated albumin specifically.
The enhanced renal clearance of glycated albumin in normal
rats and in nonproteinuric diabetic rats is possibly due to
alterations in the biochemical characteristics of albumin follow-
ing nonenzymatic glycation, namely its electrical and/or struc-
tural properties. It has been shown that less anionic dextrans
[12] and albumins [13, 141 have enhanced glomerular permeabil-
ity, in line with current concepts of the effect of the charge of
circulating proteins on their transport across the glomerular
barrier [15]. However, the preferential transport of glycated
ferritin in the perfused rat kidney [16] and the enhanced
clearance of glycated albumin in normal man [2] cannot be
explained on the basis of a reduction in anionic charge, since
both glycated proteins have been observed to be more anionic
than their nonglycated counterparts [2, 16]. Evidence that
nonenzymatic glycation increases the anionic charge on rat
albumin suggests that this would inhibit its glomerular filtration.
Conversely, an increase in the anionic charge of rat albumin
would be expected to reduce its rate of tubular reabsorption
relative to nonglycated albumin [17]. Therefore, if p1 does
contribute to the increased renal clearance of glycated albumin,
it may be through decreased tubular reabsorption. Alterna-
tively, an alteration in the three-dimensional properties of
albumin following nonenzymatic glycation may influence its
rate of glomerular filtration and tubular reabsorption. This is
supported by studies in proteinuric humans revealing that
albumin with an altered tertiary structure is present in relatively
higher concentrations in urine than in serum, thereby reflecting
the enhanced renal clearance of a modified form of albumin [18,
191.
The renal clearance of glycated and native albumin has not
been previously compared in the rat. In man, the results have
been conflicting, perhaps because of methodological differ-
ences. Two different approaches have been used in previous
studies for the measurement of glycated serum and urinary
albumin. In the first, total albumin was initially isolated by
affinity chromatography and the degree of glycation was subse-
quently determined either by the thiobarbituric acid technique
[2] or by the estimation of the fucosine-tyrosine ratio in protein
digests [6]. In another approach, glycated albumin was first
separated from albumin by m-aminophenylboronate chroma-
tography and the albumin content in the two fractions was
determined by radioimmunoassay. This latter method was used
in the present study and also in two recent preliminary reports
[3, 7].
Although the chromatography technique used in this study
does not measure total glycated albumin, it is specific for
glycated protein, and unlike measurements using thiobarbituric
acid, is not affected by free glucose or aldimine concentration
[20, 211. In our study, the concentration of glycated serum
albumin was 3 to 4% of total albumin in the normal rat, which
is similar to, but slightly lower than previous estimates of 5 to
7% in the rat [12] and in man [22]. By contrast, the fucosine-
tyrosine method gives values of glycated serum albumin of 27%
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in normal man and more than twice this level in diabetics 6]. If
the fucosine-tyrosine method overestimates glycated albumin in
serum but not in urine, then this would account for a spuriously-
low renal clearance of glycated albumin.
The present study indicates that glycated albumin is prefer-
entially cleared by the kidneys in both normal and diabetic rats,
despite the increase in its anionic charge. It is possible that
factors such as modification of the tertiary structure of albumin
and differential tubular reabsorption of glycated and nongly-
cated albumin may promote the preferential excretion of gly-
cated albumin.
Reprint requests to Mr. Gary Layton, Department of Medicine,
Austin Hospital, Heidelberg, Victoria, Australia 3084.
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